deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT02540161

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Sponsor: Annick Desjardins

Conditions Malignant Glioma
Interventions Sym004 - 18 mg/kg Sym004 - 24 mg/kg
Updated 16 times since 2017 Last updated: Jul 23, 2020 Started: Feb 1, 2016 Primary completion: Jul 10, 2019 Completion: Apr 27, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Malignant Glioma, this trial is completed. The trial is conducted by Annick Desjardins and has accumulated 16 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Apr 2019 · 6 months · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 11 earlier versions

  1. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2

  2. Aug 2020 — Sep 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Sep 2019 — Aug 2020 [monthly]

    Active Not Recruiting PHASE2

  4. Jul 2019 — Sep 2019 [monthly]

    Active Not Recruiting PHASE2

  5. Apr 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Oct 2018 — Apr 2019 [monthly]

    Recruiting PHASE2

  7. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE2

  8. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  9. Jul 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

  10. Feb 2017 — Jul 2017 [monthly]

    Recruiting PHASE2

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Annick Desjardins
  • Symphogen A/S
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations